PRESS RELEASE: Phase-II-contract (No. 09 / 2018) for RIB Software SE: Mandatory implementation of the iTWO eTender platform in the State of Berlin

09:00 DGAP-News: Phase-II-Auftrag (Nr. 09 / 2018) der RIB Software SE: Verbindliche Anwendung der iTWO eVergabe Plattform im Land Berlin 09:00 DGAP-News: Phase-II-contract (No. 09 / 2018) for RIB Software SE: Mandatory implementation of the iTWO eTender ...

Press Release: Novartis JULIET trial of Kymriah demonstrates more than one-year durability of responses in adults with relapsed or refractory DLBCL

patient's first response (n=48) was 65% (95% CI, 49%-78%). In fact, 54% (13/24) of patients who had achieved a PR converted to CR, including two said Samit Hirawat, MD, Head, Novartis Oncology Global Drug Development. "Novartis is committed to bringing ...

Press Release: Novartis survey uncovers real-world impact of immune thrombocytopenia or ITP, a rare blood disease, on patients' quality of life

symptom at diagnosis (71%) and at survey completion (64%). "Severe fatigue, in particular, was reported by many patients as the most difficult to manage symptom of ITP," said Nichola Cooper, MD, clinical senior lecturer, Hammersmith Hospital, Imperial ...